| 07/01/2026 7:41 AM | Coe Mary Ellen (1691304) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 7:44 AM | Karsanbhai Surendralal Lanca (1754881) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 7:47 AM | Merck & Co., Inc. (310158) Issuer Seidman Christine E (1805745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2026 2:08 PM | Merck & Co., Inc. (310158) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/24/2026 2:12 PM | Merck & Co., Inc. (310158) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/24/2026 2:05 PM | Merck & Co., Inc. (310158) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/02/2026 2:31 PM | Karsanbhai Surendralal Lanca (1754881) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:26 PM | Coe Mary Ellen (1691304) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:09 PM | LAVIZZO-MOUREY RISA J (1034465) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:11 PM | Mayo Stephen (1849061) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:14 PM | Merck & Co., Inc. (310158) Issuer Rothman Paul (1601332) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for MRK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Merck & Co., Inc. and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/02/2026 1:17 PM | Merck & Co., Inc. (310158) Issuer RUSSO PATRICIA F (1023219) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:19 PM | Merck & Co., Inc. (310158) Issuer Seidman Christine E (1805745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:21 PM | Merck & Co., Inc. (310158) Issuer THULIN INGE G (1263739) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 12:57 PM | BAKER DOUGLAS M JR (1198753) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:03 PM | Craig Pamela J. (1232910) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:05 PM | GLOCER THOMAS H (1140799) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 12:24 PM | Merck & Co., Inc. (310158) Filer | Form SD Specialized Disclosure Report | |
| 05/22/2026 3:21 PM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 7:14 AM | Merck & Co., Inc. (310158) Filer | Form 424B5 | |
| 05/13/2026 3:06 PM | Merck & Co., Inc. (310158) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 05/07/2026 11:10 AM | Litchfield Caroline (1854928) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 11:14 AM | Merck & Co., Inc. (310158) Issuer Williams David Michael (1820958) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 11:18 AM | Merck & Co., Inc. (310158) Issuer Zachary Jennifer (1737231) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:52 AM | Davis Robert M (1363076) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:56 AM | DeLuca Richard R. (1421339) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 11:03 AM | Larson Betty D (1617903) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 11:07 AM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:39 AM | Merck & Co., Inc. (310158) Issuer Smart Dalton E. III (2003375) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:42 AM | Merck & Co., Inc. (310158) Issuer Oosthuizen Johannes Jacobus (1916310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:45 AM | Maraldo David R. (2126478) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:48 AM | Foard Brian (2119564) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:36 AM | Guindo Chirfi (1722753) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 12:47 PM | Maraldo David R. (2126478) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 12:51 PM | Merck & Co., Inc. (310158) Issuer Smart Dalton E. III (2003375) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 12:08 PM | Maraldo David R. (2126478) Reporting Merck & Co., Inc. (310158) Issuer | Form 3/A | |
| 05/05/2026 7:52 AM | Merck & Co., Inc. (310158) Filed by Terns Pharmaceuticals, Inc. (1831363) Subject | Form SC TO-T/A | |
| 05/04/2026 5:28 PM | Maraldo David R. (2126478) Reporting Merck & Co., Inc. (310158) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/01/2026 5:54 PM | Guindo Chirfi (1722753) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 5:32 PM | Chattopadhyay Sanat (1670690) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 5:20 PM | DeLuca Richard R. (1421339) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Iran War Shock: What I Was Told In That Private Meeting (Ad) You’re Being LIED To About The Iran War
Forget EVERYTHING you’ve heard about the Iran war.
Especially the reasons why we’re bombing the country. Because THIS is the real reason. |
| 05/01/2026 4:55 PM | Merck & Co., Inc. (310158) Issuer Smart Dalton E. III (2003375) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:56 PM | Merck & Co., Inc. (310158) Issuer Williams David Michael (1820958) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:38 PM | Davis Robert M (1363076) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:39 PM | Litchfield Caroline (1854928) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:42 PM | Larson Betty D (1617903) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:43 PM | Merck & Co., Inc. (310158) Issuer Zachary Jennifer (1737231) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:45 PM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:34 PM | Merck & Co., Inc. (310158) Issuer Oosthuizen Johannes Jacobus (1916310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 10:44 AM | Merck & Co., Inc. (310158) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/30/2026 5:53 AM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/24/2026 6:30 AM | Merck & Co., Inc. (310158) Filed by Terns Pharmaceuticals, Inc. (1831363) Subject | Form SC TO-T/A | |
| 04/08/2026 3:25 PM | Merck & Co., Inc. (310158) Filer | Form DEF 14A | |
| 04/08/2026 3:28 PM | Merck & Co., Inc. (310158) Filer | Form DEFA14A | |
| 04/07/2026 6:00 AM | Merck & Co., Inc. (310158) Filed by Terns Pharmaceuticals, Inc. (1831363) Subject | Form SC TO-T | |
| 04/01/2026 12:42 PM | Coe Mary Ellen (1691304) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 12:44 PM | GLOCER THOMAS H (1140799) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 12:47 PM | Merck & Co., Inc. (310158) Issuer Seidman Christine E (1805745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 9:31 AM | Merck & Co., Inc. (310158) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/12/2026 12:52 PM | Foard Brian (2119564) Reporting Merck & Co., Inc. (310158) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/10/2026 3:38 PM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/06/2026 3:10 PM | Guindo Chirfi (1722753) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:12 PM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:13 PM | Litchfield Caroline (1854928) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:15 PM | Merck & Co., Inc. (310158) Issuer Oosthuizen Johannes Jacobus (1916310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 3:38 PM | Merck & Co., Inc. (310158) Subject Smart Dalton E. III (2003375) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/04/2026 3:26 PM | Litchfield Caroline (1854928) Reporting Merck & Co., Inc. (310158) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/04/2026 3:27 PM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/04/2026 3:29 PM | Davis Robert M (1363076) Reporting Merck & Co., Inc. (310158) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/03/2026 5:38 AM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/28/2026 3:09 PM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/28/2026 3:10 PM | Litchfield Caroline (1854928) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/28/2026 3:12 PM | Merck & Co., Inc. (310158) Issuer Oosthuizen Johannes Jacobus (1916310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/28/2026 3:18 PM | Merck & Co., Inc. (310158) Issuer Williams David Michael (1820958) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/28/2026 3:19 PM | Merck & Co., Inc. (310158) Issuer Zachary Jennifer (1737231) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/07/2026 7:55 AM | Cidara Therapeutics, Inc. (1610618) Subject Merck & Co., Inc. (310158) Filed by | Form SC TO-T/A | |
| 01/05/2026 11:20 AM | GLOCER THOMAS H (1140799) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 11:22 AM | Merck & Co., Inc. (310158) Issuer Seidman Christine E (1805745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 11:16 AM | Coe Mary Ellen (1691304) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/19/2025 3:06 PM | Cidara Therapeutics, Inc. (1610618) Subject Merck & Co., Inc. (310158) Filed by | Form SC TO-T/A | |
| 12/17/2025 4:15 PM | Cidara Therapeutics, Inc. (1610618) Subject Merck & Co., Inc. (310158) Filed by | Form SC TO-T/A | |
| 12/05/2025 4:08 PM | Cidara Therapeutics, Inc. (1610618) Subject Merck & Co., Inc. (310158) Filed by | Form SC TO-T | |
| 12/04/2025 3:36 PM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/03/2025 3:22 PM | Merck & Co., Inc. (310158) Filer | Form 424B5 | |
| 12/01/2025 7:19 PM | Merck & Co., Inc. (310158) Subject | Form FWP | |
| 12/01/2025 7:13 AM | Merck & Co., Inc. (310158) Filer | Form 424B5 | |
| 11/04/2025 3:02 PM | Merck & Co., Inc. (310158) Issuer Williams David Michael (1820958) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/30/2025 5:40 AM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/02/2025 8:28 AM | Coe Mary Ellen (1691304) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 8:29 AM | GLOCER THOMAS H (1140799) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 8:31 AM | Merck & Co., Inc. (310158) Issuer Seidman Christine E (1805745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad) Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states.
The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. See which companies control the supply chain behind this emerging tech |
| 09/09/2025 3:33 PM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/02/2025 7:15 AM | Merck & Co., Inc. (310158) Filer | Form 424B5 | |
| 08/13/2025 4:05 PM | Merck & Co., Inc. (310158) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 08/05/2025 7:43 AM | Guindo Chirfi (1722753) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:46 AM | Merck & Co., Inc. (310158) Issuer Williams David Michael (1820958) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |